In conclusion, the present work provides additional evidence that MT5-MMP contributes to the pathophysiology of AD, and that the underlying mechanisms include, at least in part, the ability of the MMP to promote APP trafficking into amyloidogenic pathways that remain to be thoroughly investigated. Here, APP is linked to Alzheimer disease.